Reovirus transcriptase activation in vitro: further studies on the facilitation phenomenon.
D000818:Animals; D002586:Cesium / Q000494:pharmacology; D002918:Chymotrypsin / Q000494:pharmacology; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D004789:Enzyme Activation / Q000187:drug effects; D007531:Isoflurophate / Q000494:pharmacology; D007700:Kinetics; D007739:L Cells; D051379:Mice; D011188:Potassium / Q000494:pharmacology; D012087:Reoviridae / Q000187:drug effects / Q000201:enzymology* / Q000648:ultrastructure; D012413:Rubidium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013025:Glycine max; D013054:Spectrophotometry, Atomic; D013997:Time Factors; D014105:Tosyl Compounds / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D014105:Tosyl Compounds; D014361:Trypsin Inhibitors; D007531:Isoflurophate; D002586:Cesium; D012964:Sodium; D012321:DNA-Directed RNA Polymerases; D002918:Chymotrypsin; D012413:Rubidium; D011188:Potassium